-
Wil Research Europe - Lyon
- Vice President, Scientific Operation
2014 - maintenant
-
Sanofi Pasteur
- Senior Director, Quality Control Laboratories, Sanofi Pasteur, Lyon, France
Lyon
2010 - 2014
Currently managing the Quality Control Laboratories, a department (350 people) with 6 business units (virology, bacteriology, physico-chemistry/immunochemistry, in vivo testing, raw materials, logistics) involved in the quality control of vaccines (bulk and final products) under cGMP rules. Quality control of vaccines includes release, in process control, and stability testing. This position requires working with supply chain, accounting, and human resources on a daily basis and includes managing capabilities and facilities (5 separate buildings, a total of 14000 m2). It also includes deployment of a new organization, new managerial practices (“lean laboratories”), and new laboratory tools (e.g.: automation and a global LIMS).
-
Sanofi Pasteur
- Director Quality Control, Biological Assays, Sanofi Pasteur, Lyon, France
Lyon
2009 - 2010
Responsible for Managing a business unit (73 people) involved in the quality control (activity and safety testing) of vaccines (bulk and final products) under cGMP rules. This position required with supply chain, accounting, human ressources on a daily basis and included managing capabilities and facilities (3 separate buildings, a total of 7500 m2). It also included deployment of a new organization and new managerial practices.
-
Merck and Co. (MSD)
- Director Toxicology
Lyon
2006 - 2009
Responsible for managing 12 direct reports with a total span of control of 51 people as follows: 6 toxicologists with various degree of experience, 1 administrative assistant, 3 toxicology laboratory supervisors (each of them with 11 direct reports), 1 clinical pathology manager (with 7 direct reports).
-
Merck and Co. (MSD)
- Associate Director, Head of Toxicology Laboratories, Merck & Co., Riom, France
Lyon
2005 - 2006
Responsible for managing 5 direct reports with a total span of control of 38 people as follows: 2 junior toxicologists and 3 toxicology laboratory supervisors (each of them with 11 toxicology technicians).
-
Merck and Co. (MSD)
- Toxicologist, Senior Research Fellow, Merck & Co., Riom, France
Lyon
2004 - 2005
Study director for studies in general, reproductive, and genetic toxicology (exploratory and range-finding studies; 2-week to 12-month toxicity studies; carcinogenicity studies; fertility, pre- and post-natal developmental toxicity and teratogenicity studies; micronucleus, AMES, alkaline elution, and chromosomal aberration assays).
Study monitor for studies contracted out at RCC, Ltd, CH and MDS Pharma Services, F.
-
Merck and Co. (MSD)
- Compound Manager Preclinical Safety Evaluation, Merck & Co., Riom, France
Lyon
2004 - 2009
Toxicology project team representative responsible for defining and executing the preclinical development strategy (toxicology, toxicokinetic, safety pharmacological, and stability studies) of small molecules developed for various programs (anti-infectious, cardiovascular, respiratory and CNS compounds). Successfully completed IND, CIB, IMPD, and CSA filings and agency correspondences worldwide to progress compounds into various phases of development (phases 1, 2, and 3).
Toxicology representative responsible for evaluating preclinical safety package in due diligence teams for various potential licensed-in compounds.
-
Merck and Co. (MSD)
- Toxicologist, Research Fellow, Merck & Co., Riom, France & West Point, PA, USA
Lyon
2000 - 2004
Study director for studies in general, reproductive, and genetic toxicology (exploratory and range-finding studies; 2-week to 12-month toxicity studies; carcinogenicity studies; fertility, pre- and post-natal developmental toxicity and teratogenicity studies; micronucleus, AMES, alkaline elution, and chromosomal aberration assays).
Completed interim assignments (6 months in 2000 and 7 months in 2002) in Safety Assessment, Merck & Co. at West Point, PA, USA.
-
Pfizer
- Toxicologist, Pfizer, Amboise, France
Paris
1995 - 1999
Toxicology project team representative responsible for execution and associated risk analysis of toxicity findings on various programs (antifungal, benign prostate hyperplasia, wound healing compounds).
Study director for studies in general and reproductive toxicology (exploratory and range-finding studies ; 1- to 6-month toxicity studies; fertility, pre- and post-natal developmental toxicity and teratogenicity studies; topical toxicity studies).
Study monitor for studies contracted out at Scantox, DK and MDS Pharma Services, Lyon, F.
-
Ecole Nationale Vétérinaire de Nantes, France
- Lecturer, Department of Pharmacy/Toxicology, Veterinary School of Nantes, F.
1993 - 1994
